Skip to content
Tuesday, November 17, 2026 · Today’s edition, 6:30 a.m. ETTue, Nov 17 · 6:30 a.m. editionSign inMy Desk 0EditionsSign in

Who holds CLDXCELLDEX THERAPEUTICS

11 funds on our shelf carry CELLDEX THERAPEUTICS — heaviest hand: SBIO at 1.49% of its book.

FundWeightFund assetsShares held
SBIOALPS Medical Breakthroughs ETFACTIVE1.49%$114M96,167
SURISimplify Propel Opportunities ETFACTIVE0.89%$75M21,629
WDNAWisdomTree BioRevolution FundACTIVE0.72%$3M1,175
BBCVirtus Biotech Clinical Trials ETF0.71%—8,004
XBIState Street SPDR S&P Biotech ETFINDEX0.47%$10.3B1,654,349
TMSLT. Rowe Price Small-Mid Cap ETFACTIVE0.15%$192M178,398
FFSMFidelity Fundamental Small-Mid Cap ETFINDEX0.14%$86M71,410
LABUDirexion Daily S&P Biotech Bull 3X ETFINDEX0.10%$624M61,454
PWSPacer WealthShield ETFACTIVE0.09%$20M511
VHTVanguard Health Care Index FundINDEX0.03%$19B210,818
FHLCFidelity MSCI Health Care Index ETFINDEX0.02%$3.2B36,060

LATEST DISCLOSED BOOKS ON THE ENRICHED SHELF · THE SHELF GROWS NIGHTLY AS READERS RESEARCH NEW FUNDS

ETF Dailyfrom Private Wealth Daily

ETF launches, fund research, and market coverage in your inbox every morning. Free.

Free. Every morning. Unsubscribe from any edition in one click.